August has a habit of humbling investors. The VIX sits at 17.09, well off the March 2026 peak of 31.05, but the pattern is familiar: quiet summer tape, thin liquidity, and a single headline that can send correlations to one. That is precisely when long-duration, cash-generative dividend payers earn their keep. With the 10-year Treasury yielding 4.68% and sitting near the 98.8 percentile of its 12-month range, the bar for equity income is high. The three names below clear it by compounding yield over decades.
Here is the thesis: brand moats plus multi-decade dividend growth streaks equal an income stream that survives every cycle. Consider them in August. Built to hold for decades.
McDonald’s (NYSE: MCD)
McDonald’s (NYSE:MCD | MCD Price Prediction) is the definition of a forever compounder testing investor patience. Shares are down 10.35% year to date and off 7.62% over the past year, closing at $270.64 on July 31. That marks a notable pullback. Zoom out and the stock is up 192.63% over the past decade, and the analyst consensus target sits at $323.90.
The dividend engine is the story. McDonald’s raised its quarterly payout to $1.86 beginning with the Q1 2026 payment, up from $1.77 in 2025 and $0.55 back in 2010. The 49th consecutive annual increase (declared October 2025) puts the company one hike away from Dividend King status. Q1 2026 delivered EPS of $2.83 against $2.74 expected, revenue of $6.52 billion (+9.4% year over year), and global comparable sales up 3.8%. CEO Chris Kempczinski noted, "McDonald’s delivered this quarter. Our 6% global systemwide sales growth shows how we executed with discipline."
At a trailing P/E of 22 and a beta of 0.418, the risk-adjusted setup is compelling. Risk: U.S. company-owned margins face inflationary pressure, and the company carries negative shareholders’ equity of -$1.79 billion alongside restructuring charges running through 2027.
Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson (NYSE:JNJ) is the counterweight to McDonald’s summer slump. Shares closed at $256.35 on July 31, up 25.25% year to date and 59.5% over the past year. That is capital rotating into quality earnings.
The dividend story is unmatched. JNJ raised its quarterly payout to $1.34, marking 64 consecutive years of increases confirmed in April 2026. The next ex-dividend date is August 25, 2026, with payment September 8. Q1 2026 revenue hit $24.06 billion, up 9.9% year over year, with adjusted EPS of $2.70 beating estimates. Innovative Medicine grew 11.2%, led by DARZALEX at $3.96 billion (+22.5%) and TREMFYA at $1.61 billion (+68.3%). Management raised full-year guidance to revenue of $100.3 to $101.3 billion and adjusted EPS of $11.45 to $11.65.
CEO Joaquin Duato framed the trajectory bluntly: "Johnson & Johnson had a strong start to 2026 and is delivering on its promise for a year of accelerated growth and impact." Add the $50 billion oncology sales target by 2030 and the June 2026 Firefly Bio acquisition ($1 billion), and this is a Dividend King with a growth pipeline.
Risk: STELARA biosimilar erosion created a roughly 920 basis point drag, and the planned Orthopaedics separation carries execution risk. The forward P/E of 23 also leaves less margin for error than the trailing 12 months suggest.
Realty Income (NYSE: O)
Realty Income (NYSE:O) is the pure income play. Shares closed at $63.87, up 16.76% year to date. The 4.90% dividend yield tops the 10-year Treasury, and unlike the bond, this cash flow grows.
The monthly dividend was raised to $0.271 per share, paid August 14, marking the 114th consecutive quarterly increase and the 670th consecutive monthly dividend. Q1 2026 AFFO per share came in at $1.13, up 6.6% year over year. Management deployed $2.8 billion at a 7.1% initial weighted average cash yield and raised full-year investment volume guidance to $9.5 billion from $8.0 billion. Portfolio occupancy sits at 98.9%, and 2026 AFFO guidance was raised to $4.41 to $4.44.
CEO Sumit Roy captured the momentum: "Given the strong momentum across the business, we are increasing our 2026 AFFO per share guidance range to $4.41 to $4.44." Realty Income has delivered a 13.6% average annual total return since its 1994 NYSE listing, per Motley Fool coverage from May 2026.
Risk: Q1 included $129.3 million in impairment provisions and a $39.1 million credit loss allowance increase. With rates near 12-month highs, further Treasury upside would cap multiple expansion for the sector.
Three sectors. Three moats. One thesis: reliable, rising cash back to shareholders, month after month, quarter after quarter, decade after decade. August volatility is when quality income holdings tend to prove their worth.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks